NO994685L - Diagnostiske midler for pankreatisk eksokrin funksjon - Google Patents
Diagnostiske midler for pankreatisk eksokrin funksjonInfo
- Publication number
- NO994685L NO994685L NO994685A NO994685A NO994685L NO 994685 L NO994685 L NO 994685L NO 994685 A NO994685 A NO 994685A NO 994685 A NO994685 A NO 994685A NO 994685 L NO994685 L NO 994685L
- Authority
- NO
- Norway
- Prior art keywords
- labeled
- salt
- diagnostic agents
- pancreatic exocrine
- exocrine function
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/189—Host-guest complexes, e.g. cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1206—Administration of radioactive gases, aerosols or breath tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1268—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Materials Engineering (AREA)
- Medical Informatics (AREA)
- Atmospheric Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27125398 | 1998-09-25 | ||
JP27125298 | 1998-09-25 | ||
JP26197999A JP3669880B2 (ja) | 1998-09-25 | 1999-09-16 | 膵外分泌機能診断剤 |
JP26330099A JP4031599B2 (ja) | 1998-09-25 | 1999-09-17 | 膵外分泌機能診断剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO994685D0 NO994685D0 (no) | 1999-09-24 |
NO994685L true NO994685L (no) | 2000-03-27 |
NO329283B1 NO329283B1 (no) | 2010-09-27 |
Family
ID=27478602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19994685A NO329283B1 (no) | 1998-09-25 | 1999-09-24 | 13C-merket oligosakkarid eller polysakkarid og anvendelse av slike ved fremstilling av diagnostisk middel for pankreatisk eksokrin funksjon |
Country Status (11)
Country | Link |
---|---|
US (1) | US6254851B1 (no) |
EP (2) | EP0989137B1 (no) |
AT (2) | ATE459654T1 (no) |
AU (1) | AU755444B2 (no) |
CA (2) | CA2283518C (no) |
DE (2) | DE69933832T2 (no) |
DK (2) | DK1386934T3 (no) |
ES (2) | ES2275330T3 (no) |
NO (1) | NO329283B1 (no) |
NZ (2) | NZ337946A (no) |
PT (2) | PT989137E (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3340699B2 (ja) * | 1998-06-05 | 2002-11-05 | 東京瓦斯株式会社 | 膵外分泌機能診断剤 |
US6905668B1 (en) * | 1998-09-25 | 2005-06-14 | Tokyo Gas Company Limited | Diagnostic agents for pancreatic exocrine function |
US7232559B1 (en) | 1999-06-04 | 2007-06-19 | Tokyo Gas Company Limited | Diagnostic agents for pancreatic exocrine function |
JP2001139498A (ja) * | 1999-11-15 | 2001-05-22 | Tokyo Gas Co Ltd | 膵外分泌機能診断剤 |
EP1316320A4 (en) * | 2000-09-07 | 2005-12-07 | Tokyo Gas Co Ltd | PREPARATIONS FOR DIAGNOSING THE EXTRAPANCREATIC SECRETION FUNCTION |
AUPS293002A0 (en) * | 2002-06-14 | 2002-07-04 | Women's And Children's Hospital | Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders |
JP5097823B2 (ja) * | 2008-06-05 | 2012-12-12 | 株式会社日立ハイテクノロジーズ | イオンビーム装置 |
RU2552927C2 (ru) * | 2010-03-13 | 2015-06-10 | Истпонд Лабораториз Лимитед | Жиросвязывающая композиция |
US8480769B2 (en) | 2010-07-29 | 2013-07-09 | Air Products And Chemicals, Inc. | Method for gasification and a gasifier |
FR3054564B1 (fr) | 2016-07-28 | 2018-08-31 | Advanced Biodesign | Substrat specifique d'une isoenzyme de l'aldh |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1945663C3 (de) | 1969-09-10 | 1981-11-26 | Meyer-Bertenrath, Jürgen, Prof. Dr.Dr., 6450 Hanau | Diagnostikum zur Bestimmung von Pankreas-Enzymen in Körperflüssigkeiten |
DE2314270A1 (de) | 1973-03-22 | 1974-09-26 | Boehringer Mannheim Gmbh | Hochwirksame zubereitungsform von fluoresceinestern und verfahren zur herstellung derselben |
US4676974A (en) | 1984-05-17 | 1987-06-30 | The Regents Of The University Of California | Breath test for pancreatic exocrine function |
EP0220951A3 (en) | 1985-10-25 | 1988-12-14 | Celgene Corporation | Biochemicals labelled with stable isotopes |
US5405975A (en) * | 1993-03-29 | 1995-04-11 | Molecular Probes, Inc. | Fluorescent ion-selective diaryldiaza crown ether conjugates |
GB2251381B (en) | 1990-07-19 | 1995-01-25 | Charwell Pharma | Emulsified fluorescein diester diagnostic compositions |
US5300280A (en) | 1992-02-14 | 1994-04-05 | Mallinckrodt Medical, Inc. | Stabilized radiopharmaceutical kits |
DE4426204C2 (de) | 1993-07-24 | 2001-05-23 | Infai Inst Fuer Biomedizinisch | Diagnostikum und seine Verwendung |
US5543621A (en) | 1995-05-15 | 1996-08-06 | San Jose State University Foundation | Laser diode spectrometer for analyzing the ratio of isotopic species in a substance |
DE19812332A1 (de) | 1998-03-20 | 1999-09-23 | Reinhold Horlacher | Verfahren zur Synthese von ·1··3·C- oder ·1··4·C-markierten linearen Maltodextrinen sowie zyklischen Maltodextrinen mittels einfacher Reaktionen durch mikrobielle Enzyme sowie diese Mikroorganismen selbst |
-
1999
- 1999-09-21 NZ NZ337946A patent/NZ337946A/en not_active IP Right Cessation
- 1999-09-21 NZ NZ507949A patent/NZ507949A/en not_active IP Right Cessation
- 1999-09-22 AU AU48865/99A patent/AU755444B2/en not_active Ceased
- 1999-09-23 US US09/401,739 patent/US6254851B1/en not_active Expired - Fee Related
- 1999-09-24 PT PT99307554T patent/PT989137E/pt unknown
- 1999-09-24 ES ES99307554T patent/ES2275330T3/es not_active Expired - Lifetime
- 1999-09-24 CA CA002283518A patent/CA2283518C/en not_active Expired - Fee Related
- 1999-09-24 DK DK03077521.7T patent/DK1386934T3/da active
- 1999-09-24 DK DK99307554T patent/DK0989137T3/da active
- 1999-09-24 EP EP99307554A patent/EP0989137B1/en not_active Expired - Lifetime
- 1999-09-24 AT AT03077521T patent/ATE459654T1/de not_active IP Right Cessation
- 1999-09-24 AT AT99307554T patent/ATE344281T1/de not_active IP Right Cessation
- 1999-09-24 PT PT03077521T patent/PT1386934E/pt unknown
- 1999-09-24 NO NO19994685A patent/NO329283B1/no not_active IP Right Cessation
- 1999-09-24 CA CA002451924A patent/CA2451924C/en not_active Expired - Fee Related
- 1999-09-24 EP EP03077521A patent/EP1386934B1/en not_active Expired - Lifetime
- 1999-09-24 ES ES03077521T patent/ES2339932T3/es not_active Expired - Lifetime
- 1999-09-24 DE DE69933832T patent/DE69933832T2/de not_active Expired - Lifetime
- 1999-09-24 DE DE69942106T patent/DE69942106D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU4886599A (en) | 2000-03-30 |
EP1386934B1 (en) | 2010-03-03 |
US6254851B1 (en) | 2001-07-03 |
AU755444B2 (en) | 2002-12-12 |
CA2283518A1 (en) | 2000-03-25 |
DK1386934T3 (da) | 2010-06-14 |
NO329283B1 (no) | 2010-09-27 |
ATE459654T1 (de) | 2010-03-15 |
CA2451924C (en) | 2008-03-11 |
DE69942106D1 (de) | 2010-04-15 |
EP0989137A3 (en) | 2000-10-11 |
PT989137E (pt) | 2006-12-29 |
ES2339932T3 (es) | 2010-05-27 |
DE69933832D1 (de) | 2006-12-14 |
DE69933832T2 (de) | 2007-06-14 |
NZ337946A (en) | 2001-11-30 |
EP1386934A1 (en) | 2004-02-04 |
PT1386934E (pt) | 2010-04-27 |
NZ507949A (en) | 2002-03-01 |
DK0989137T3 (da) | 2006-12-11 |
ATE344281T1 (de) | 2006-11-15 |
CA2283518C (en) | 2005-07-12 |
EP0989137B1 (en) | 2006-11-02 |
ES2275330T3 (es) | 2007-06-01 |
CA2451924A1 (en) | 2000-03-25 |
EP0989137A2 (en) | 2000-03-29 |
NO994685D0 (no) | 1999-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
NO994685L (no) | Diagnostiske midler for pankreatisk eksokrin funksjon | |
BR9804214A (pt) | Compostos. | |
TR200101906T2 (tr) | Antiviral ajanlar olarak kuinolinkarboksamitler | |
DE60009511D1 (de) | Nematizide trifluorbutene | |
ATE463478T1 (de) | Diaryletherderivat, dessen additionssalz und immunosuppressivum | |
PT842934E (pt) | Agonistas de 5-ht1f | |
TNSN97075A1 (fr) | Complexes d'inclusion de sels aryl-heterocycliques | |
NO20055283L (no) | Karbohydrat-derivater av rapamycin | |
PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
IT1311922B1 (it) | Composti farmaceutici. | |
YU72594A (sh) | Vodeni rastvor inkluzionih kompleksa benzotiofen jedinjenja sa vodorastvornim ciklodekstrinima, njegove farmaceutske formulacije i postupci za dobijanje | |
FI19992070A (fi) | Uudet fukosyloidut oligosakkaridit ja menetelmä niiden valmistamiseksi | |
ATE237359T1 (de) | Zyklodextrin-zusammensetzung enthaltend ein avermectin- oder ein milbemycin-derivat | |
MA27094A1 (fr) | Derives triazolo-quinoline utiles en tant que ligands recepteurs d'adenosine. | |
ATE250021T1 (de) | Hydroxycyclopentanone | |
ATE451382T1 (de) | 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung | |
ES2169220T3 (es) | Derivados de vitamina d3 con sustituyentes en la posicion 2. | |
EA200000092A1 (ru) | Противоаллергические средства | |
IL135634A0 (en) | 5-htif agonists | |
DE60105801D1 (de) | Naphtholderivate | |
MY115907A (en) | Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation | |
TR199902510T2 (xx) | 7alfa-metil-17alfa-etinil-estran t�revlerinin aterosklerozun tedavi edilmesi i�in kullan�m�. | |
WO2006094217A8 (en) | Agent and method for colouring keratin fibres | |
CA2031528A1 (en) | Radionuclide metal chelates for the radiolabeling of proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |